Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

July 08, 2010

Genzyme Corporation v. Watson Laboratories, Inc.

Track this case

Case Number:

1:10-cv-01863

Court:

Maryland

Nature of Suit:

Patent

Judge:

J. Frederick Motz

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 12, 2010

    Genzyme Sues Watson Over Renvela Powder ANDA

    Genzyme Corp. has filed a patent infringement suit in an effort to block a Watson Pharmaceuticals Inc. unit from producing a generic version of kidney disease treatment Renvela in powder form, on the heels of a dispute between the rivals over the tablet form of the drug.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login